When a major bank declines a medical practice refinance, the deal isn't dead. The triggers that move a practice file to a non-bank specialist lender.

How lenders read the hygienist-to-associate equity step in 2026: what gets approved, what gets reshaped, and how vendor-finance overlap is structured.

Three doors open for a manufacturer in 2026: family buy-out, roll-up acquisition, or greenfield expansion. A finance map for each path.

After a family manufacturer buy-out, the home loan file changes shape. How a One Doc Home Loan handles the post-handover income switch and DTI test.

Roll-up acquisition or greenfield expansion? How a mid-tier Australian manufacturer files each growth path with the lender in 2026.

How a SMSF buys a manufacturer's factory in 2026, from the underwriter's seat. BRP test, LRBA, related-party rent, LVR ceiling, in-house asset cross-check.

A family manufacturer buy-out generates a fresh file. Here is what the bank reads first, where the earnout sits, and the personal-side cleanup.

Caveat, second mortgage or secured working capital, choose by speed, cost, exit and first-charge position. Decision tree for self-employed.

How a non-bank One Doc home loan reads a live caveat on title, with approval letter conditions dissected line by line for self-employed borrowers.

How property security reshapes working capital loan limits, pricing, cross-collateral risk and release timing for self-employed Australian business owners.